{"id":"https://openalex.org/W4361237893","doi":"https://doi.org/10.1158/0008-5472.c.6507980","title":"Data from Antibody-Targeted Chemotherapy for the Treatment of Melanoma","display_name":"Data from Antibody-Targeted Chemotherapy for the Treatment of Melanoma","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361237893","doi":"https://doi.org/10.1158/0008-5472.c.6507980"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6507980","doi":"https://doi.org/10.1158/0008-5472.c.6507980","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6507980","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.c.6507980","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054678780","display_name":"Wendy Kay Nevala","orcid":"https://orcid.org/0009-0004-2256-6715","observed_orcids":["https://orcid.org/0009-0004-2256-6715"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wendy K. Nevala","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012302982","display_name":"Sarah A. Buhrow","orcid":"https://orcid.org/0009-0003-5723-5409","observed_orcids":["https://orcid.org/0009-0003-5723-5409"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarah A. Buhrow","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114247100","display_name":"Daniel J. Knauer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel J. Knauer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027416118","display_name":"Joel M. Reid","orcid":"https://orcid.org/0000-0003-2872-3123","observed_orcids":["https://orcid.org/0000-0003-2872-3123"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joel M. Reid","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112466166","display_name":"Elena A. Atanasova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elena A. Atanasova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5082719040","display_name":"Svetomir N. Markovic","orcid":"https://orcid.org/0000-0002-9238-4325","observed_orcids":["https://orcid.org/0000-0002-9238-4325"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Svetomir N. Markovic","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9545999765396118,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9545999765396118,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.01679999940097332,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.875},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.7369999885559082},{"id":"https://openalex.org/keywords/nab-paclitaxel","display_name":"nab-paclitaxel","score":0.9610000252723694},{"id":"https://openalex.org/keywords/albumin-nanoparticles","display_name":"albumin nanoparticles","score":0.906000018119812},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.968999981880188},{"id":"https://openalex.org/keywords/anti-vegf-monoclonal-antibody","display_name":"anti-VEGF monoclonal antibody","score":0.9089999794960022},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.5809999704360962},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.7360000014305115}],"concepts":[{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.7752630114555359},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6619574427604675},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6275099515914917},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.621627926826477},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6067970395088196},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5957123637199402},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5435081124305725},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.511566698551178},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49131718277931213},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.43225085735321045},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22604915499687195},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.21188461780548096}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6507980","doi":"https://doi.org/10.1158/0008-5472.c.6507980","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6507980","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6507980","doi":"https://doi.org/10.1158/0008-5472.c.6507980","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6507980","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.41999998688697815,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3142026086","https://openalex.org/W2028827184","https://openalex.org/W2146312028","https://openalex.org/W3146277049","https://openalex.org/W2767564966","https://openalex.org/W4200337742","https://openalex.org/W4246588393","https://openalex.org/W2101180062","https://openalex.org/W3209693064","https://openalex.org/W2030499865"],"abstract_inverted_index":{"Abstract":[0],"Antibody-directed":[1],"chemotherapy":[2,9,51,132],"(ADC)":[3],"offers":[4],"an":[5],"advantage":[6],"over":[7],"conventional":[8],"because":[10],"it":[11],"provides":[12],"antibody-directed":[13],"targeting,":[14],"with":[15,27,100],"resultant":[16],"improvement":[17],"in":[18,75,81,111,153,167,186],"therapeutic":[19,179],"efficacy":[20,166],"and":[21,45,85,105,127,158,195],"reduced":[22,46],"toxicity.":[23],"Despite":[24],"extensive":[25],"research,":[26],"notable":[28],"exceptions,":[29],"broad":[30],"clinical":[31],"application":[32],"of":[33,42,49,72,115,125],"ADC":[34],"remains":[35],"elusive;":[36],"major":[37],"hurdles":[38],"include":[39],"the":[40,50,55,69,97,122,131,139,142,149,161],"instability":[41],"antibody\u2013chemotherapy":[43],"linkers":[44],"tumor":[47],"toxicity":[48],"when":[52,148],"bound":[53],"to":[54,94,144],"antibody.":[56],"To":[57],"address":[58],"these":[59],"challenges,":[60],"we":[61,120],"have":[62,90],"developed":[63,91],"a":[64,92,112,154,168],"platform":[65],"technology":[66],"that":[67,130,160,177],"utilizes":[68],"nab-paclitaxel":[70],"formulation":[71],"paclitaxel,":[73],"Abraxane,":[74,128],"which":[76,189],"hydrophobic":[77],"paclitaxel":[78],"is":[79],"suspended":[80],"130-nm":[82],"albumin":[83],"nanoparticles":[84],"thus":[86],"made":[87],"water-soluble.":[88],"We":[89],"method":[93],"noncovalently":[95],"coat":[96],"Abraxane":[98,107],"nanoparticle":[99,156,162],"recombinant":[101],"mAbs":[102],"(anti-VEGF,":[103],"bevacizumab)":[104],"guide":[106],"delivery":[108],"into":[109],"tumors":[110],"preclinical":[113,169],"model":[114],"human":[116,170],"A375":[117],"melanoma.":[118],"Here,":[119],"define":[121],"binding":[123],"characteristics":[124],"bevacizumab":[126],"demonstrate":[129],"agent":[133],"retains":[134],"its":[135,146],"cytotoxic":[136],"effect,":[137],"while":[138],"antibody":[140],"maintains":[141],"ability":[143],"bind":[145],"ligand":[147],"two":[150],"are":[151],"present":[152],"single":[155],"(AB160),":[157],"show":[159],"yields":[163],"improved":[164],"antitumor":[165],"melanoma":[171],"xenograft":[172],"model.":[173],"Further":[174],"data":[175],"suggest":[176],"numerous":[178],"monoclonal":[180],"IgG1":[181],"antibodies":[182],"may":[183],"be":[184],"utilized":[185],"this":[187],"platform,":[188],"has":[190],"implications":[191],"for":[192],"many":[193],"solid":[194],"hematologic":[196],"malignancies.":[197],"Cancer":[198],"Res;":[199],"76(13);":[200],"3954\u201364.":[201],"\u00a92016":[202],"AACR.":[203]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-10T00:00:00"}